All Pathways
Colorectal SurgeryManagement

IBD Surgical Indications Algorithm (ASCRS)

IBD Surgical Indications Algorithm (ASCRS): Adult with UC or Crohn's disease: is surgery indicated? → Before surgery: steroids, nutrition, pregnancy, ch...

Pathway Overview

17 steps

Algorithm Steps

17 total

  1. 01Start

    Adult with UC or Crohn's disease: is surgery indicated?

    Decide with the IBD multidisciplinary team (gastroenterology and colorectal surgery). Involve surgery early in moderate to severe disease.

  2. 02Warning

    Before surgery: steroids, nutrition, pregnancy, children

    These factors raise the risk of leak and sepsis or put the patient outside this pathway.

    • On or recently on steroids: give perioperative steroid (hydrocortisone) cover. Prednisolone above 20 mg/day, malnutrition, anaemia or smoking: optimise first if time allows, or stage the operation or add a diverting stoma. Do not delay surgery only because of biologic therapy.
    • Pregnancy: plan with obstetrics, IBD and colorectal surgery; this pathway does not cover it.
    • Child or adolescent: refer to a paediatric IBD surgical team.
  3. 03Decision

    Which disease: UC or Crohn's?

  4. UC
  5. 04Decision

    UC: what is the indication for surgery?

  6. Emergency or urgent
  7. 05Action

    UC emergency or urgent: total abdominal colectomy + end ileostomy

    For fulminant UC, toxic megacolon, perforation, refractory bleeding, or acute severe UC not responding to IV steroids and rescue therapy. Leave the rectum in situ. Decide on pouch or other reconstruction later, after recovery.

    • Acute severe UC with no response by 7 days of rescue therapy (infliximab or ciclosporin), or worse before that: colectomy.
    • Exclude C. difficile and CMV in severe colitis.
  8. 06End

    After any UC operation: VTE prophylaxis, leak watch, surveillance

    Consider extended chemical VTE prophylaxis after discharge, unless there is active bleeding or a high bleeding risk. After IPAA, look early for anastomotic leak (pelvic sepsis). Keep endoscopic surveillance of any retained rectum or pouch.

  9. Dysplasia or cancer
  10. 07Action

    UC dysplasia or cancer: MDT; proctocolectomy if not removable endoscopically

    Proctocolectomy (with or without IPAA) for high-grade dysplasia or worse, persistently invisible or multifocal dysplasia, dysplasia not fully removable endoscopically, or any dysplasia with PSC. Visible low-grade dysplasia fully removed endoscopically: close surveillance.

    • Invisible dysplasia: first repeat high-definition chromoendoscopy by an expert endoscopist.
    • Indefinite for dysplasia with active inflammation: treat the inflammation, then reassess after mucosal healing.
    • Cancer: oncological resection planned by the colorectal cancer MDT.
    • Pelvic radiation for IBD rectal cancer impairs pouch outcomes: plan the pouch with the MDT.
  11. Path rejoins step 06Shared downstream outcome
  12. Refractory (elective)
  13. 08Action

    UC refractory to medical therapy: elective proctocolectomy

    For chronic active disease despite medical therapy, steroid dependence, or intolerance of therapy. Discuss both options: restorative (IPAA, J-pouch) and non-restorative (end ileostomy).

    • Stage the operation (colectomy first) if on steroids or advanced therapies, malnourished or unwell.
    • Selected patients with relative rectal sparing: colectomy + ileorectal anastomosis (rectal surveillance needed).
    • IPAA less suitable: poor anal sphincter function; features of Crohn's disease. Discuss effects on fertility, pregnancy, sexual and urinary function.
    • Older age: IPAA possible in selected patients; higher complication rates.
  14. Path rejoins step 06Shared downstream outcome
  15. Crohn's
  16. 09Decision

    Crohn's: what is the indication for surgery?

  17. Emergency
  18. 10Action

    Crohn's emergency: operate

    Free perforation: resect the perforated segment (not simple repair). Severe colitis not responding to medical therapy: total abdominal colectomy + end ileostomy. Bleeding with instability despite resuscitation: operate; targeted resection if the source is found.

    • Stable bleeding: CT angiography, endoscopy or interventional radiology first.
  19. 11End

    After any Crohn's operation: plan medical therapy to prevent recurrence

    Agree postoperative medical therapy with gastroenterology to treat residual disease or maintain remission. Support smoking cessation. Give VTE prophylaxis in hospital (IBD raises VTE risk) unless there is active bleeding.

  20. Stricture
  21. 12Decision

    Crohn's stricture: small bowel (including duodenum) or colon?

  22. Small bowel, duodenum or anastomosis
  23. 13Action

    Small bowel, duodenal or anastomotic stricture: dilate, stricturoplasty, resect

    No stricturoplasty with perforation, inflammatory mass, cancer, dysplasia or severe malnutrition. Inflammatory stricture: medical therapy first. Short (under 5 cm) fibrotic stricture without abscess or fistula: endoscopic balloon dilation. Dilation fails or unsuitable: limited resection (about 2 cm margins) or stricturoplasty to save bowel length.

    • Biopsy suspicious lesions before stricturoplasty.
    • Stricturoplasty by length: Heineke-Mikulicz under 10 cm; Finney 10 to 25 cm; isoperistaltic side-to-side over 25 cm.
    • Multiple strictures or risk of short bowel: prefer stricturoplasty, alone or with resection.
    • Stomach or duodenum: endoscopic dilation, bypass or stricturoplasty.
  24. Path rejoins step 11Shared downstream outcome
  25. Colon
  26. 14Action

    Colonic stricture: colonoscopy with multiple biopsies first

    2% to 6% of colonic Crohn's strictures contain dysplasia or cancer. If the stricture cannot be fully assessed endoscopically: resect by oncological principles. Colonic stricturoplasty is generally discouraged.

    • Benign on full assessment: endoscopic dilation is an option.
  27. Path rejoins step 11Shared downstream outcome
  28. Abscess or fistula
  29. 15Action

    Crohn's abscess or fistula: control sepsis first

    Start anti-TNF only after antibiotics and drainage. Intra-abdominal abscess: IV antibiotics; percutaneous drainage if large (under 3 cm: antibiotics alone may do). Then interval resection or medical therapy. Enteric fistula that persists despite medical therapy: resect the diseased bowel.

    • Perianal abscess or fistula: examination under anaesthesia, drain sepsis, loose (draining) seton, combined with medical therapy.
    • A fistula alone does not always need surgery (no malabsorption, severe diarrhoea or recurrent infection).
  30. Path rejoins step 11Shared downstream outcome
  31. Refractory
  32. 16Action

    Crohn's refractory to medical therapy: resect by site

    Ileocolic or small bowel: limited resection with about 2 cm margins, by MDT; early resection is an option in limited non-stricturing ileocaecal disease. Colon with rectal sparing: segmental colectomy (one segment) or total colectomy + ileorectal anastomosis. Rectal disease: proctocolectomy + end ileostomy.

    • Also consider for steroid dependence or intolerance of medical therapy.
    • IPAA only in selected patients without perianal or small-bowel disease; higher pouch failure.
    • After surgery: medical therapy to prevent recurrence.
  33. Path rejoins step 11Shared downstream outcome
  34. Dysplasia or cancer
  35. 17Action

    Crohn's dysplasia or cancer: MDT; total colectomy or proctocolectomy

    Visible dysplasia fully removed endoscopically: surveillance. Dysplasia not removable endoscopically, also in flat mucosa, multifocal, or cancer: total colectomy or proctocolectomy by oncological principles.

    • Invisible dysplasia: repeat high-definition colonoscopy with chromoendoscopy by an expert within 3 to 6 months first.
  36. Path rejoins step 11Shared downstream outcome

Guideline Source

ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • For adults. Surgical decisions need the IBD MDT; this pathway gives indications, not operative technique.
  • Crohn's disease is not cured by surgery and often recurs; save bowel length. Proctocolectomy removes UC but pouch complications are common.
  • Perianal Crohn's disease is covered only in outline; see ASCRS 2022 anorectal fistula guideline.

Contraindicated Populations

Children and adolescents (paediatric IBD surgical team)Pregnancy (joint obstetric, IBD and colorectal surgical care)

Applicable Regions

USAUUKEU

AU: No separate Australian surgical guideline; ASCRS and ECCO are used

EU: ECCO surgical guidelines for UC (2026) and Crohn's disease

UK: BSG IBD guideline 2019

US: ASCRS guidelines (Crohn's 2020, UC 2026)

Version 2Next review: 2027-09-30

Frequently Asked Questions

What is the IBD Surgical Indications Algorithm (ASCRS)?

The IBD Surgical Indications Algorithm (ASCRS) is a management clinical algorithm for Colorectal Surgery. It provides a structured decision tree to guide clinical decision-making, based on ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026).

What guideline is the IBD Surgical Indications Algorithm (ASCRS) based on?

This algorithm is based on ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026) (DOI: 10.1097/DCR.0000000000001716).

What are the limitations of the IBD Surgical Indications Algorithm (ASCRS)?

Known limitations include: For adults. Surgical decisions need the IBD MDT; this pathway gives indications, not operative technique.; Crohn's disease is not cured by surgery and often recurs; save bowel length. Proctocolectomy removes UC but pouch complications are common.; Perianal Crohn's disease is covered only in outline; see ASCRS 2022 anorectal fistula guideline.. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the IBD Surgical Indications Algorithm (ASCRS) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free